Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncology Pharma, Inc. (ONPH)
:ONPH
Holding ONPH?
Track your performance easily
ONPH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.06 - $0.06
Previous CloseN/A
Volume1.38K
Average Volume (3M)13.11K
Market Cap
$2.74K
Enterprise ValueN/A
Total Cash (Recent Filing)$5.83M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta224.50
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding27,388,216
10 Day Avg. Volume2,547
30 Day Avg. Volume13,111
Standard Deviation34.15
R-Squared0.00
Alpha8.33
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
ONPH FAQ
What was Oncology Pharma, Inc.’s price range in the past 12 months?
Oncology Pharma, Inc. lowest stock price was $0.06 and its highest was $0.06 in the past 12 months.
What is Oncology Pharma, Inc.’s market cap?
Oncology Pharma, Inc.’s market cap is $2.74K.
When is Oncology Pharma, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Oncology Pharma, Inc.’s earnings last quarter?
Currently, no data Available
Is Oncology Pharma, Inc. overvalued?
According to Wall Street analysts Oncology Pharma, Inc.’s price is currently Overvalued.
Does Oncology Pharma, Inc. pay dividends?
Oncology Pharma, Inc. does not currently pay dividends.
What is Oncology Pharma, Inc.’s EPS estimate?
Oncology Pharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncology Pharma, Inc. have?
Oncology Pharma, Inc. has 27,388,216 shares outstanding.
What happened to Oncology Pharma, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Oncology Pharma, Inc.?
Currently, no hedge funds are holding shares in ONPH
---
Company Description
Oncology Pharma, Inc.
Oncology Pharma, Inc. engages in the development, manufacture and commercialization of therapeutics. Its portfolio include Nanosmart Pharmaceuticals, and Tulynode. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.
---
---